Geriatric Medicine Market, Global Outlook and Forecast 2022-2028

March 2022 | 62 pages | ID: G446458AC779EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Geriatric Medicine in Global, including the following market information:

Global Geriatric Medicine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Geriatric Medicine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Analgesics Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Geriatric Medicine include GSK, Boehringer Ingelheim, Novartis, Bristol-Myers Squibb, Pfizer, Eli Lilly, Abbott, AstraZeneca and Merck and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Geriatric Medicine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Geriatric Medicine Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Geriatric Medicine Market Segment Percentages, by Type, 2021 (%)

• Analgesics
• Antihypertensives
• Statins
• Antidiabetics
• Proton Pump Inhibitor
• Anticoagulant
• Antipsychotic
• Antidepressant

Global Geriatric Medicine Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Geriatric Medicine Market Segment Percentages, by Application, 2021 (%)

• Cardiovascular
• Arthritis
• Neurological
• Cancer
• Osteoporosis
• Respiratory

Global Geriatric Medicine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Geriatric Medicine Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Geriatric Medicine revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Geriatric Medicine revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• GSK
• Boehringer Ingelheim
• Novartis
• Bristol-Myers Squibb
• Pfizer
• Eli Lilly
• Abbott
• AstraZeneca
• Merck
• Sanofi S.A.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Geriatric Medicine Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Geriatric Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GERIATRIC MEDICINE OVERALL MARKET SIZE

2.1 Global Geriatric Medicine Market Size: 2021 VS 2028
2.2 Global Geriatric Medicine Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Geriatric Medicine Players in Global Market
3.2 Top Global Geriatric Medicine Companies Ranked by Revenue
3.3 Global Geriatric Medicine Revenue by Companies
3.4 Top 3 and Top 5 Geriatric Medicine Companies in Global Market, by Revenue in 2021
3.5 Global Companies Geriatric Medicine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Geriatric Medicine Players in Global Market
  3.6.1 List of Global Tier 1 Geriatric Medicine Companies
  3.6.2 List of Global Tier 2 and Tier 3 Geriatric Medicine Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Geriatric Medicine Market Size Markets, 2021 & 2028
  4.1.2 Analgesics
  4.1.3 Antihypertensives
  4.1.4 Statins
  4.1.5 Antidiabetics
  4.1.6 Proton Pump Inhibitor
  4.1.7 Anticoagulant
  4.1.8 Antipsychotic
  4.1.9 Antidepressant
4.2 By Type - Global Geriatric Medicine Revenue & Forecasts
  4.2.1 By Type - Global Geriatric Medicine Revenue, 2017-2022
  4.2.2 By Type - Global Geriatric Medicine Revenue, 2023-2028
  4.2.3 By Type - Global Geriatric Medicine Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Geriatric Medicine Market Size, 2021 & 2028
  5.1.2 Cardiovascular
  5.1.3 Arthritis
  5.1.4 Neurological
  5.1.5 Cancer
  5.1.6 Osteoporosis
  5.1.7 Respiratory
5.2 By Application - Global Geriatric Medicine Revenue & Forecasts
  5.2.1 By Application - Global Geriatric Medicine Revenue, 2017-2022
  5.2.2 By Application - Global Geriatric Medicine Revenue, 2023-2028
  5.2.3 By Application - Global Geriatric Medicine Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Geriatric Medicine Market Size, 2021 & 2028
6.2 By Region - Global Geriatric Medicine Revenue & Forecasts
  6.2.1 By Region - Global Geriatric Medicine Revenue, 2017-2022
  6.2.2 By Region - Global Geriatric Medicine Revenue, 2023-2028
  6.2.3 By Region - Global Geriatric Medicine Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Geriatric Medicine Revenue, 2017-2028
  6.3.2 US Geriatric Medicine Market Size, 2017-2028
  6.3.3 Canada Geriatric Medicine Market Size, 2017-2028
  6.3.4 Mexico Geriatric Medicine Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Geriatric Medicine Revenue, 2017-2028
  6.4.2 Germany Geriatric Medicine Market Size, 2017-2028
  6.4.3 France Geriatric Medicine Market Size, 2017-2028
  6.4.4 U.K. Geriatric Medicine Market Size, 2017-2028
  6.4.5 Italy Geriatric Medicine Market Size, 2017-2028
  6.4.6 Russia Geriatric Medicine Market Size, 2017-2028
  6.4.7 Nordic Countries Geriatric Medicine Market Size, 2017-2028
  6.4.8 Benelux Geriatric Medicine Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Geriatric Medicine Revenue, 2017-2028
  6.5.2 China Geriatric Medicine Market Size, 2017-2028
  6.5.3 Japan Geriatric Medicine Market Size, 2017-2028
  6.5.4 South Korea Geriatric Medicine Market Size, 2017-2028
  6.5.5 Southeast Asia Geriatric Medicine Market Size, 2017-2028
  6.5.6 India Geriatric Medicine Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Geriatric Medicine Revenue, 2017-2028
  6.6.2 Brazil Geriatric Medicine Market Size, 2017-2028
  6.6.3 Argentina Geriatric Medicine Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Geriatric Medicine Revenue, 2017-2028
  6.7.2 Turkey Geriatric Medicine Market Size, 2017-2028
  6.7.3 Israel Geriatric Medicine Market Size, 2017-2028
  6.7.4 Saudi Arabia Geriatric Medicine Market Size, 2017-2028
  6.7.5 UAE Geriatric Medicine Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 GSK
  7.1.1 GSK Corporate Summary
  7.1.2 GSK Business Overview
  7.1.3 GSK Geriatric Medicine Major Product Offerings
  7.1.4 GSK Geriatric Medicine Revenue in Global Market (2017-2022)
  7.1.5 GSK Key News
7.2 Boehringer Ingelheim
  7.2.1 Boehringer Ingelheim Corporate Summary
  7.2.2 Boehringer Ingelheim Business Overview
  7.2.3 Boehringer Ingelheim Geriatric Medicine Major Product Offerings
  7.2.4 Boehringer Ingelheim Geriatric Medicine Revenue in Global Market (2017-2022)
  7.2.5 Boehringer Ingelheim Key News
7.3 Novartis
  7.3.1 Novartis Corporate Summary
  7.3.2 Novartis Business Overview
  7.3.3 Novartis Geriatric Medicine Major Product Offerings
  7.3.4 Novartis Geriatric Medicine Revenue in Global Market (2017-2022)
  7.3.5 Novartis Key News
7.4 Bristol-Myers Squibb
  7.4.1 Bristol-Myers Squibb Corporate Summary
  7.4.2 Bristol-Myers Squibb Business Overview
  7.4.3 Bristol-Myers Squibb Geriatric Medicine Major Product Offerings
  7.4.4 Bristol-Myers Squibb Geriatric Medicine Revenue in Global Market (2017-2022)
  7.4.5 Bristol-Myers Squibb Key News
7.5 Pfizer
  7.5.1 Pfizer Corporate Summary
  7.5.2 Pfizer Business Overview
  7.5.3 Pfizer Geriatric Medicine Major Product Offerings
  7.5.4 Pfizer Geriatric Medicine Revenue in Global Market (2017-2022)
  7.5.5 Pfizer Key News
7.6 Eli Lilly
  7.6.1 Eli Lilly Corporate Summary
  7.6.2 Eli Lilly Business Overview
  7.6.3 Eli Lilly Geriatric Medicine Major Product Offerings
  7.6.4 Eli Lilly Geriatric Medicine Revenue in Global Market (2017-2022)
  7.6.5 Eli Lilly Key News
7.7 Abbott
  7.7.1 Abbott Corporate Summary
  7.7.2 Abbott Business Overview
  7.7.3 Abbott Geriatric Medicine Major Product Offerings
  7.7.4 Abbott Geriatric Medicine Revenue in Global Market (2017-2022)
  7.7.5 Abbott Key News
7.8 AstraZeneca
  7.8.1 AstraZeneca Corporate Summary
  7.8.2 AstraZeneca Business Overview
  7.8.3 AstraZeneca Geriatric Medicine Major Product Offerings
  7.8.4 AstraZeneca Geriatric Medicine Revenue in Global Market (2017-2022)
  7.8.5 AstraZeneca Key News
7.9 Merck
  7.9.1 Merck Corporate Summary
  7.9.2 Merck Business Overview
  7.9.3 Merck Geriatric Medicine Major Product Offerings
  7.9.4 Merck Geriatric Medicine Revenue in Global Market (2017-2022)
  7.9.5 Merck Key News
7.10 Sanofi S.A.
  7.10.1 Sanofi S.A. Corporate Summary
  7.10.2 Sanofi S.A. Business Overview
  7.10.3 Sanofi S.A. Geriatric Medicine Major Product Offerings
  7.10.4 Sanofi S.A. Geriatric Medicine Revenue in Global Market (2017-2022)
  7.10.5 Sanofi S.A. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Geriatric Medicine Market Opportunities & Trends in Global Market
Table 2. Geriatric Medicine Market Drivers in Global Market
Table 3. Geriatric Medicine Market Restraints in Global Market
Table 4. Key Players of Geriatric Medicine in Global Market
Table 5. Top Geriatric Medicine Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Geriatric Medicine Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Geriatric Medicine Revenue Share by Companies, 2017-2022
Table 8. Global Companies Geriatric Medicine Product Type
Table 9. List of Global Tier 1 Geriatric Medicine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Geriatric Medicine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Geriatric Medicine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Geriatric Medicine Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Geriatric Medicine Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Geriatric Medicine Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Geriatric Medicine Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Geriatric Medicine Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Geriatric Medicine Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Geriatric Medicine Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Geriatric Medicine Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Geriatric Medicine Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Geriatric Medicine Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Geriatric Medicine Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Geriatric Medicine Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Geriatric Medicine Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Geriatric Medicine Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Geriatric Medicine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Geriatric Medicine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Geriatric Medicine Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Geriatric Medicine Revenue, (US$, Mn), 2023-2028
Table 30. GSK Corporate Summary
Table 31. GSK Geriatric Medicine Product Offerings
Table 32. GSK Geriatric Medicine Revenue (US$, Mn), (2017-2022)
Table 33. Boehringer Ingelheim Corporate Summary
Table 34. Boehringer Ingelheim Geriatric Medicine Product Offerings
Table 35. Boehringer Ingelheim Geriatric Medicine Revenue (US$, Mn), (2017-2022)
Table 36. Novartis Corporate Summary
Table 37. Novartis Geriatric Medicine Product Offerings
Table 38. Novartis Geriatric Medicine Revenue (US$, Mn), (2017-2022)
Table 39. Bristol-Myers Squibb Corporate Summary
Table 40. Bristol-Myers Squibb Geriatric Medicine Product Offerings
Table 41. Bristol-Myers Squibb Geriatric Medicine Revenue (US$, Mn), (2017-2022)
Table 42. Pfizer Corporate Summary
Table 43. Pfizer Geriatric Medicine Product Offerings
Table 44. Pfizer Geriatric Medicine Revenue (US$, Mn), (2017-2022)
Table 45. Eli Lilly Corporate Summary
Table 46. Eli Lilly Geriatric Medicine Product Offerings
Table 47. Eli Lilly Geriatric Medicine Revenue (US$, Mn), (2017-2022)
Table 48. Abbott Corporate Summary
Table 49. Abbott Geriatric Medicine Product Offerings
Table 50. Abbott Geriatric Medicine Revenue (US$, Mn), (2017-2022)
Table 51. AstraZeneca Corporate Summary
Table 52. AstraZeneca Geriatric Medicine Product Offerings
Table 53. AstraZeneca Geriatric Medicine Revenue (US$, Mn), (2017-2022)
Table 54. Merck Corporate Summary
Table 55. Merck Geriatric Medicine Product Offerings
Table 56. Merck Geriatric Medicine Revenue (US$, Mn), (2017-2022)
Table 57. Sanofi S.A. Corporate Summary
Table 58. Sanofi S.A. Geriatric Medicine Product Offerings
Table 59. Sanofi S.A. Geriatric Medicine Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Geriatric Medicine Segment by Type in 2021
Figure 2. Geriatric Medicine Segment by Application in 2021
Figure 3. Global Geriatric Medicine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Geriatric Medicine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Geriatric Medicine Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Geriatric Medicine Revenue in 2021
Figure 8. By Type - Global Geriatric Medicine Revenue Market Share, 2017-2028
Figure 9. By Application - Global Geriatric Medicine Revenue Market Share, 2017-2028
Figure 10. By Region - Global Geriatric Medicine Revenue Market Share, 2017-2028
Figure 11. By Country - North America Geriatric Medicine Revenue Market Share, 2017-2028
Figure 12. US Geriatric Medicine Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Geriatric Medicine Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Geriatric Medicine Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Geriatric Medicine Revenue Market Share, 2017-2028
Figure 16. Germany Geriatric Medicine Revenue, (US$, Mn), 2017-2028
Figure 17. France Geriatric Medicine Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Geriatric Medicine Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Geriatric Medicine Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Geriatric Medicine Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Geriatric Medicine Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Geriatric Medicine Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Geriatric Medicine Revenue Market Share, 2017-2028
Figure 24. China Geriatric Medicine Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Geriatric Medicine Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Geriatric Medicine Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Geriatric Medicine Revenue, (US$, Mn), 2017-2028
Figure 28. India Geriatric Medicine Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Geriatric Medicine Revenue Market Share, 2017-2028
Figure 30. Brazil Geriatric Medicine Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Geriatric Medicine Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Geriatric Medicine Revenue Market Share, 2017-2028
Figure 33. Turkey Geriatric Medicine Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Geriatric Medicine Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Geriatric Medicine Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Geriatric Medicine Revenue, (US$, Mn), 2017-2028
Figure 37. GSK Geriatric Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Boehringer Ingelheim Geriatric Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis Geriatric Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bristol-Myers Squibb Geriatric Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pfizer Geriatric Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Eli Lilly Geriatric Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Abbott Geriatric Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. AstraZeneca Geriatric Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Merck Geriatric Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Sanofi S.A. Geriatric Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)